Research on the Role of Post-Translational Modifications in Human Health and Disease
When beginning your next investigator-initiated application, consider the following NIH highlighted topic. The area of science described below is of interest to the listed NIH Institutes, Centers, and Offices (ICOs). This is not a notice of funding opportunity (NOFO).
Apply through an appropriate NIH Parent Funding Announcement or another broad NIH opportunity available on Grants.gov. Learn how to interpret and use Highlighted Topics.
Topic Description
Post Date: June 26, 2026
Expiration Date: June 26, 2028
Purpose
This topic encourages research to examine the mechanistic roles of understudied post-translation modifications (PTMs) and PTM crosstalk in the biology of human health and disease, such as cancer.
Background
PTMs are crucial to biological processes, enabling cells to respond and adapt to extrinsic and intrinsic stimuli, and perform a central regulatory mechanism in normal cellular function, organismal development, tissue maintenance, and stress response. PTMs exert their various functions by impacting different aspects of protein behavior, including enzymatic activity, stability, interactions with other molecules, and subcellular localization.
To date, more than 400 different kinds of PTMs have been detected, about one fourth of which have been linked to human diseases. Among these, phosphorylation, acetylation, methylation and ubiquitination account for the largest number of known disease-associated modifications. Others, such as glycosylation, lactylation, serotonylation, sumoylation, myristoylation and succinylation, etc., remain understudied. It remains poorly understood how varied PTMs crosstalk synergistically or antagonistically to influence protein function and localization, and overall cellular state. This knowledge gap raises important questions regarding the true extent of disease-associated PTMs and what other roles and functions of PTMs have been overlooked due to the focus on a narrowly defined set of modifications. Adding to the challenges, current PTM research (including crosstalk) mostly concentrates on a few proteins such as histones, transcription factors (TFs) and signaling molecules. Broadening the repertoire of PTMs and their substrates will enable a broader understanding of their complex interplay and biological significance in human health and disease.
Recent technological breakthroughs in PTM identification and characterization offers an untapped potential to study diverse PTMs, their crosstalk, and coordinated roles in health and disease. These include computational methodologies, mass spectrometry enrichment techniques, adoption of unnatural amino acids and mimetics, bio-orthogonal chemistry, single-cell omics technologies, and utilization of AlphaFold protein structure databases. Furthermore, advancements in targeted protein degradation and the development of chemical inducers of proximity offer pioneering approaches to interrogate disease-relevant protein-PTMs.
This topic encourages applications that promote:
- mechanistic research on novel functions of understudied and lesser known PTMs; PTM substrates besides histones, TFs and signaling molecules; PTM crosstalk; and spatiotemporal dynamics of PTMs in human health and disease
- leveraging and development of advanced technologies for PTM discovery and mechanistic characterization
- interdisciplinary collaboration between PTM experts, cell biologists, data scientists, computational modelers, chemists, and biophysicists to examine understudied PTMs and their crosstalk
Participating ICOs
PTMs are known to play a role in every hallmark of cancer, enhance protein complexity, and expand the various cellular functions necessary for adaptive biological responses but several key knowledge gaps remain. A deeper understanding of the mechanisms linking PTMs to cancer biology could reveal unappreciated roles, uncover unifying principles that govern cancer hallmark features and unveil novel vulnerabilities. Scientific areas of interest focusing on cancer initiation, growth, and progression include:
- dissecting mechanisms of understudied PTMs, PTM crosstalk, and PTM code-dependent substrate function
- elucidating the dynamic role of PTMs in modulation of cell states, adaptive responses, and/or the spatio-temporal heterogeneity of the tumor ecosystem
- defining the role of PTM readers, writers, and erasers
- integration of tumor PTM data with other omics data
- evaluating PTM-based biomarkers for cancer risk assessment, early detection, disease interception, and prevention strategies.
Ruibai Luo, Ph.D. (Cancer cell biology)
[email protected]
Natalia Mercer, Ph.D. (Stromal biology)
[email protected]
Michael Weinreich, Ph.D. (Nuclear cell biology)
[email protected]
Wanping Xu, Ph.D. (Cancer cell biology)
[email protected]
Cindy W. Kyi, Ph.D. (Technology development)
[email protected]
Nicholas Hodges, Ph.D. (Biomarkers)
[email protected]
PTMs constitute a dynamic regulatory language that governs proteome function across the lifespan. Emerging evidence suggests that altered PTM crosstalk and declining fidelity of PTM writers, erasers, and readers are central features of biological aging and linked to age-related diseases (ARD) including Alzheimer’s disease (AD) and related dementias (ADRD). Defining the PTM code in aging, ARD, and AD/ADRD will reveal mechanistic drivers of functional decline and identify actionable targets for intervention. Scientific areas of interest include:
- Generating systems-level maps of PTM landscapes across tissues, cell types, sex, and lifespan
- Studying PTM crosstalk and hierarchical signaling networks
- Defining temporal dynamics distinguishing adaptive vs. maladaptive PTM remodeling
- Integrating multi-omics data linking PTMs to transcriptomic, epigenomic, and metabolic changes
- Developing validated PTM-based biomarkers and intervention targets to promote resilience, life, and healthspan
Andras Orosz, Ph.D.
[email protected]
Q. Alison Yao, Ph.D.
[email protected]
Nalini Raghavachari, Ph.D.
[email protected]
PTMs of histones and other proteins involved in regulating gene expression as well as PTMs of enzymes, receptors, transporters, and other synaptic proteins play a key role in inducing molecular and cellular changes that drive drug-seeking behaviors, addiction, and relapse. Recent research has revealed new PTMs that contribute to multiple addiction-relevant behaviors. NIDA is interested in research that leverages proteomics, single-cell and subcellular multiomic technologies to study:
- New and understudied PTMs and their roles across different stages of substance use and addiction
- PTMs, PTM crosstalk, and molecular mechanisms that influence neuronal plasticity, circuit function, and substance use vulnerability
- Sex specific differences and hormonal influences on PTMs and PTM-mediated effects on substance use
- PTM-based biomarkers and selective modulators of PTM enzymes for development of therapeutics
- Changes in PTMs due to HIV infection, polysubstance use and other comorbid conditions
Subramaniam Ananthan, Ph.D.
[email protected]
Jason Wan, PhD
[email protected]
For technical issues E-mail OER Webmaster